Literature DB >> 7068768

Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells.

W Wharton, G Y Gillespie, S W Russell, W J Pledger.   

Abstract

The culture medium from several murine macrophage-like cell lines contained a mitogenic activity that functioned synergistically with platelet-poor plasma to induce DNA synthesis in quiescent density-inhibited BALB/c 3T3 fibroblasts. This mitogenic activity was generated by P388D1 (and other established lines of) macrophage-like cells that were cultured either in medium alone or in medium supplemented with platelet-poor plasma. The amount of mitogenic activity produced was directly related to the length of time the macrophage-like cells were maintained in the medium. Serum-free medium conditioned by macrophage-cells did not stimulate DNA synthesis in density-inhibited 3T3 cells in the absence of plasma; however, a transient (4-hr) exposure to serum-free macrophage-conditioned medium allowed quiescent cells to respond to plasma-derived progression factors. The addition of plasma to 3T3 cells that had been treated with the macrophage-conditioned medium brought about DNA synthesis after a 12-hr lag. The mitogenic activity that was in macrophage-conditioned medium bound to DEAE-Sephadex and eluted in a single peak using a linear NaCl gradient. This macrophage-derived competence factor was not mitogenic for lymphocytes and was clearly separated by DEAE-Sephadex chromatography from the major peak of the previously described mitogenic monokine, Interleukin-1 (lymphocyte activating factor).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7068768     DOI: 10.1002/jcp.1041100115

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

Review 1.  Pathogenesis of silicosis: current concepts and hypotheses.

Authors:  G S Davis
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production.

Authors:  S H Phan; S L Kunkel
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

3.  Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis.

Authors:  W Wharton; E Leof; W J Pledger; E J O'Keefe
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

Review 4.  The golden age of mononuclear phagocytes.

Authors:  G Y Gillespie
Journal:  Surv Immunol Res       Date:  1982

5.  Growth factors derived from a human malignant glioma cell line, U-251MG.

Authors:  J Kuratsu; J E Estes; S Yokota; M S Mahaley; G Y Gillespie
Journal:  J Neurooncol       Date:  1989-09       Impact factor: 4.130

6.  Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis.

Authors:  J A Schmidt; C N Oliver; J L Lepe-Zuniga; I Green; I Gery
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

7.  Macrophage-derived growth factor for osteoblast-like cells and chondrocytes.

Authors:  L Rifas; V Shen; K Mitchell; W A Peck
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Stimulation of human monocyte/macrophage-derived growth factor (MDGF) production by plasma fibronectin.

Authors:  B M Martin; M A Gimbrone; G R Majeau; E R Unanue; R S Cotran
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

9.  Lymphokine regulation of macrophage-derived growth factor secretion following pulmonary injury.

Authors:  E J Kovacs; J Kelley
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

10.  Purified monocyte-derived angiogenic substance (angiotropin) induces controlled angiogenesis associated with regulated tissue proliferation in rabbit skin.

Authors:  M Höckel; W Jung; P Vaupel; H Rabes; C Khaledpour; J H Wissler
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.